Sano, Lyrill T.
HRN: 15-93-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2022
CEFUROXIME 750MG (VIAL)
10/22/2022
10/29/2022
IVTT
400mg
Q8
Pcap, Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes